The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

B Vogel, M Acevedo, Y Appelman, CNB Merz… - The Lancet, 2021 - thelancet.com
Cardiovascular disease is the leading cause of death in women. Decades of grassroots
campaigns have helped to raise awareness about the impact of cardiovascular disease in …

The role of exosomes and exosomal microRNA in cardiovascular disease

D Zheng, M Huo, B Li, W Wang, H Piao… - Frontiers in cell and …, 2021 - frontiersin.org
Exosomes are small vesicles (30–150 nm in diameter) enclosed by a lipid membrane
bilayer, secreted by most cells in the body. They carry various molecules, including proteins …

[PDF][PDF] 2017 ESC/EACTS Guidelines for the management of valvular heart disease

H Baumgartner, V Falk, JJ Bax… - Polish Heart …, 2018 - journals.viamedica.pl
Recenzenci dokumentu: Marco Roffi, koordynator recenzji ze strony CPG (Szwajcaria),
Ottavio Alfieri1, koordynator recenzji ze strony EACTS (Włochy), Stefan Agewall (Norwegia) …

Global, regional, and national burden of rheumatic heart disease, 1990–2015

DA Watkins, CO Johnson, SM Colquhoun… - New england journal …, 2017 - Mass Medical Soc
Background Rheumatic heart disease remains an important preventable cause of
cardiovascular death and disability, particularly in low-income and middle-income countries …

[PDF][PDF] 2017 ESC/EACTS Guidelines for the management of valvular heart disease

V Falk, H Baumgartner, JJ Bax… - European Journal of …, 2017 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

Global, regional, and national burden of cardiovascular diseases in youths and young adults aged 15–39 years in 204 countries/territories, 1990–2019: a systematic …

J Sun, Y Qiao, M Zhao, CG Magnussen, B Xi - BMC medicine, 2023 - Springer
Background Understanding the temporal trends in the burden of overall and type-specific
cardiovascular diseases (CVDs) in youths and young adults and its attributable risk factors is …

Disease manifestations and pathogenic mechanisms of group A Streptococcus

MJ Walker, TC Barnett, JD McArthur… - Clinical microbiology …, 2014 - Am Soc Microbiol
Streptococcus pyogenes, also known as group A Streptococcus (GAS), causes mild human
infections such as pharyngitis and impetigo and serious infections such as necrotizing …

Aortic-valve stenosis—from patients at risk to severe valve obstruction

CM Otto, B Prendergast - New England Journal of Medicine, 2014 - Mass Medical Soc
Aortic-Valve Stenosis — From Patients at Risk to Severe Valve Obstruction | New England Journal
of Medicine Skip to main content Access provided by Charite - Universitaetsmedizin Berlin The …

The modern epidemiology of heart valve disease

S Coffey, BJ Cairns, B Iung - Heart, 2016 - heart.bmj.com
In this review, we will discuss the current knowledge of heart valve disease (HVD)
epidemiology, how it has changed over time and possible future trends. There are large …

Clinical outcomes in 3343 children and adults with rheumatic heart disease from 14 low-and middle-income countries: two-year follow-up of the Global Rheumatic …

L Zühlke, G Karthikeyan, ME Engel, S Rangarajan… - Circulation, 2016 - Am Heart Assoc
Background: There are few contemporary data on the mortality and morbidity associated
with rheumatic heart disease or information on their predictors. We report the 2-year follow …